MEDIFAST INC

For the period ended Dec 31, 2024. Filed Feb 18, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 18, 2025

MED$13.37+4.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

As of December 31, 2024 and 2023

(U.S. dollars in thousands, except par value)

	2024	2023
ASSETS
Current Assets
Cash and cash equivalents	$90,928	$94,440
Inventories, net	42,421	54,591
Investments	71,416	55,601
Income taxes, prepaid	—	8,727
Prepaid expenses and other current assets	9,639	10,670
Total current assets	214,404	224,029
Property, plant and equipment - net of accumulated depreciation	37,527	51,467
Right-of-use assets	11,155	15,645
Other assets	9,667	14,650
Deferred tax assets, net	11,460	4,117
TOTAL ASSETS	$284,213	$309,908
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Accounts payable and accrued expenses	$56,494	$86,415
Income taxes payable	1,485	—
Current lease obligations	6,182	5,885
Total current liabilities	64,161	92,300
Lease obligations, net of current lease obligations	9,943	16,127
Total liabilities	74,104	108,427
Commitments (Note 12)
Stockholders' Equity
Common stock, par value 0.001 per share: 20,000 shares authorized;
10,938 and 10,896 issued and outstanding
at December 31, 2024 and December 31, 2023	11	11
Additional paid-in capital	33,136	26,573
Accumulated other comprehensive income	180	248
Retained earnings	176,782	174,649
Total stockholders' equity	210,109	201,481
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$284,213	$309,908

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.